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Objectives. This study was performed to determine the fre-
quency of patent ductus arteriosus (PDA) reopening and the
factors that may predict reopening after successful coil occlusion.
Background. Transcatheter coil occlusion is a widely used and
accepted method to close a PDA. After documented successful coil
occlusion, we found PDAs that reopened. We hypothesized that
specific factors are involved in those that reopened.
Methods. All patients who underwent percutaneous transarte-
rial PDA coil occlusion were studied. Successful coil occlusion was
documented. PDA reopening was determined when Doppler-
echocardiography (DE) performed after the procedure was nega-
tive for PDA flow but at follow-up demonstrated PDA shunting.
Patients with a reopened PDA were compared with all other
patients in evaluating independent variables.
Results. Coil occlusion for PDA was attempted in 22 patients.
Clinical success was achieved in 20 patients (91%), and DE was
negative for PDA shunting in 19 patients (90%). At follow-up, five
patients demonstrated reopening. The PDA minimal diameter was
1.4 6 0.5 mm (mean 6 SD) for the reopened group and 1.2 6
0.7 mm for the other patients. The PDA length was 2.9 6 1.9 mm
for the reopened group and 7.1 6 3.2 mm for all other patients. All
those with type B PDA were in the reopened group. When
independent variables were compared between groups, only PDA
length and type B PDA predicted reopening (p < 0.05).
Conclusions. PDA reopening may occur after successful coil
occlusion. Short PDA length and type B PDA are associated with
reopening. The data suggest that in such anatomy, alternative
strategies to the current coil occlusion technique should be
considered.
(J Am Coll Cardiol 1998;31:444–50)
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Transcatheter occlusion for patent ductus arteriosus (PDA)
has been successfully performed with a number of devices
(1–5). Gianturco coil occlusion for PDA has become the
preferred method because of the smaller delivery system (3F to
5F), lower expense and previous experience with coils com-
pared with other transcatheter devices.
The PDA minimal diameter has been a consistent morpho-
logic feature guiding PDA coil selection, number of coils
deployed and, in some studies, overall success of the procedure
(6–10). Early experience demonstrated that PDAs with a large
minimal diameter were susceptible to coil embolization and
residual shunting (7,8). More recently, PDAs with a minimal
diameter .3.5 to 4.0 mm have been successfully occluded by
means of a multiple coil technique (9–11). Morphologic
features other than PDA diameter, such as length and shape,
have not been factors considered to correlate with success.
We have performed successful coil occlusion for PDA, with
results comparable to other institutions (6–9). Despite proce-
dural, clinical and angiographic success, we found PDAs that
reopened after documented coil occlusion. In all patients with
a reopened PDA, the PDA minimal diameter was ,3.5 mm.
Therefore, we hypothesized that factors other than minimal
diameter, such as PDA length and shape, are involved in those
that reopened. This study was performed to determine the
frequency of PDA reopening and the factors that may predict
reopening after successful coil occlusion.
Methods
Patients. Between May 1995 and June 1996, all patients
who underwent PDA coil occlusion at Columbus Children’s
Hospital were included in the study. Before being referred for
PDA coil occlusion, all patients had clinical and echocardio-
graphic findings of a PDA. Patients were excluded from coil
occlusion if they had other cardiovascular abnormalities re-
quiring operation. Written informed consent was obtained
from the parents of patients before PDA coil occlusion. The
protocol was approved by the Human Subjects Research
Committee of Columbus Children’s Hospital.
Procedure. Percutaneous transarterial PDA coil occlusion
was performed in all patients by means of the previously
described protocol (6). The femoral artery was accessed, and
either a 4F or 5F sheath was placed. The use of intravenous
heparin (50 to 75 U/kg) was based on the preference of the
interventional cardiologist. The PDA minimal diameter and
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PDA length were determined from a cineangiogram of the
descending aorta. The method for determining PDA length is
shown in Figure 1. Cephalothin was administered intrave-
nously at 25 mg/kg body weight before coil occlusion. For all
procedures, Gianturco coils of 0.38-in. wire diameter (Cook
Inc.) were used. The coil length and width were determined
using previously described criteria (6).
A descending aorta cineangiogram was performed ;10 min
after coil deployment to grade any residual shunt. A second
coil was placed if greater than a trace left to right shunt was
present. Protamine sulfate was not administered. Cardiac
auscultation was performed to document loss of the continu-
ous murmur. Cephalexin was orally administered for the next
two days at a dose of 10 mg/kg every 6 h.
Post-coil occlusion data. The success of PDA coil occlu-
sion may be defined as previously described by Lloyd et al. (6).
Procedural success was defined as coil implantation within the
PDA on the chest radiograph the morning after the procedure.
Clinical success described the loss of a continuous murmur.
Angiographic success was the absence of contrast entering the
main pulmonary artery (MPA) on the post-coil occlusion aorta
cineangiogram. Doppler-echocardiography (DE) was per-
formed in all patients within 24 h of PDA coil occlusion, with
success defined as the absence of a shunt into the MPA.
Follow-up data. Within 12 months of PDA coil occlusion,
study patients had an evaluation that included cardiac auscul-
tation, chest radiograph and DE. Cardiac auscultation defined
the presence of a systolic ejection murmur, a continuous
murmur or no murmur. The chest radiograph visually con-
firmed placement of the PDA coil. DE determined the pres-
ence or absence of a PDA shunt.
PDA reopening. PDA reopening was diagnosed when post-
procedural DE was negative for PDA flow but demonstrated
shunting at follow-up. If a new continuous murmur was present
at follow-up, we considered this to be clinical PDA reopening;
if only the Doppler study was positive at follow-up, this was
considered silent PDA reopening.
Statistical analysis. Patients with a reopened PDA after
successful coil occlusion were compared with all other patients
by logistic regression analysis evaluating age, patient weight,
mean pulmonary artery pressure, mean aortic pressure, PDA
minimal diameter, the ratio of coil diameter to PDA minimal
diameter, PDA length and the ratio of PDA minimal diameter
to PDA length. Results are expressed as mean value 6 SD.
The Fisher exact test was used to compare catheterization
date, heparin use and PDA type.
Results
Patients. The clinical data and results are summarized in
Table 1. Coil occlusion for PDA was attempted in 22 patients.
The patients ranged in age from 1.4 to 15.3 years (median 4.9)
and in weight from 10.5 to 66.7 kg (median 19.8).
Local anesthesia and conscious sedation were used for 19
procedures, and 3 were performed under general anesthesia.
Intravenous heparin was administered in 16 of 22 patients. The
mean pulmonary artery pressure ranged from 6 to 26 mm Hg
(mean 16), and the mean descending aorta pressure ranged
from 43 to 113 mm Hg (mean 77). The angiographic classifi-
cation of the ductus arteriosus (12) included 12 patients with
type A (conical with an ampulla of sufficient length), 3 with
type B (conical with a short ductal ampulla), none with type C
(tubular), 2 with type D (multiple areas of constriction within
the ductus) and 5 with type E (long conical with the narrowest
part remote from the trachea).
The PDA minimal diameter ranged from 0.5 to 2.8 mm
(mean 1.3). The coil diameter implanted was more than two
times the minimal diameter of the PDA in all cases. The PDA
Abbreviations and Acronyms
DE 5 Doppler-echocardiography
MPA 5 main pulmonary artery
PDA 5 patent ductus arteriosus
Figure 1. PDA length was measured from the straight lateral view of
the aorta cineangiogram. Length calibration used postangiogram grids.
The lateral view of the aorta cineangiogram was reviewed, and a
systolic frame that maximized the length of the ductus was chosen for
the measurement. The aortic end of the PDA was defined by a line
running parallel to the anterior surface of the descending aorta at the
level of the PDA (line A). A second line was made along the long axis
of the PDA connecting line A to the PDA–pulmonary artery junction
(point B). The length between line A and point B along the PDA long
axis was the PDA length: 5.8 mm (A); 2.3 mm (B). Ao 5 aorta; PA 5
pulmonary artery.
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length ranged from 1.0 to 12.9 mm (mean 6.2). The PDA
minimal diameter/length ratio ranged from 0.04 (long and
thin) to 1.0 (short and wide).
Occlusion results. Procedural success was achieved in 21
(95%) of 22 patients. In four patients, one coil embolized, and
in one patient three coils embolized (Patient 15). A coil was
not successfully deployed in Patient 15, and therefore dis-
charge and follow-up studies were not performed. All embo-
lized coils were retrieved by transcatheter techniques. No
shunt was detected angiographically in 14 patients (67%) and
only a trace in 7 (33%). Within 24 h of the procedure, there
was absence of a continuous murmur (clinical success) in 20
patients (95%).
DE performed before hospital discharge demonstrated no
PDA shunt in 19 of 21 patients in which a coil was successfully
deployed (90% success at hospital discharge).
Follow-up data. Follow-up evaluation for 20 patients (Pa-
tients 15 and 17 not included) averaged 6 months (range 2 to
12). Cardiac auscultation revealed a continuous murmur in
four patients. In one patient the continuous murmur repre-
sented a persistent shunt (Patient 16), whereas in the other
three, the murmur defined clinical PDA reopening. Of those
patients with follow-up chest radiographs (n 5 20), coil
position was unchanged in 19. The chest radiograph for Patient
22 documented a change in coil position (Fig. 2). DE at
follow-up demonstrated PDA shunting in six patients. In one
patient, positive Doppler study results represented a persistent
PDA shunt (Patient 16), whereas in five, shunting defined PDA
reopening.
Therefore, five patients demonstrated PDA reopening after
successful coil occlusion (three with clinical reopening, two
with silent reopening). PDA reopening was demonstrated
angiographically in patient 21 (Fig. 3).
Patients with reopened PDA versus all other patients. The
patients with PDA reopening after successful coil occlusion
(n 5 5) were compared with all other patients (n 5 17). The
data are summarized in Table 2. For the reopened PDA group,
the PDA minimal diameter ranged from 1.0 to 2.2 mm (mean
1.4 6 0.5) and the PDA length from 1.0 to 6.0 mm (mean 2.9 6
1.9). For all other patients, the PDA minimal diameter ranged
from 0.5 to 2.8 mm (mean 1.2 6 0.7) and the PDA length from
3.7 to 12.9 mm (mean 7.1 6 3.2). Figure 4 compares the PDA
minimal diameter with the PDA length for the two groups.
Logistic regression analysis of independent variables and
the Fisher exact test demonstrated that only PDA length
significantly predicted PDA reopening (p , 0.05). For PDA
length ,3.7 mm, the positive and negative predictive values for
reopening were 100% and 95%, respectively.
Type B PDA was significantly associated with the reopened
Table 1. Clinical Data and Results for 22 Patients Who Underwent Patent Ductus Arteriosus Coil Occlusion
Pt No./Age (yr)
Wt
(kg)
No. of Coils Implanted
(length [cm] 3 width [mm])
PDA
Type
PDA
Diam
(mm)
PDA
Length
(mm)
Murmur DE
Pre Post F/U 24° F/U
1/5.6 16.8 1 (5 3 5) A 1.0 5.7 C N N 2 2
2/4.9 19.6 2 (5 3 5, 4 3 3) A 2.1 5.1 C N N 2 2
3/10.6 37.4 1 (3 3 4) E 0.5 12.9 C N N 2 2
4/1.4 10.5 1 (4 3 3) A 1.5 5.8 C N S 2 2
5/7.2 22.0 1 (8 3 5) A 1.5 3.7 C N N 2 2
6/13.5 52.3 1 (5 3 5) A 0.5 6.2 C N N 2 2
7/3.8 20.0 1 (8 3 5) A 1.5 4.7 C N S 2 2
8/3.2 34.1 1 (5 3 5) D 1.9 5.4 C N N 2 2
9/2.8 13.8 1 (5 3 5) A 1.0 4.0 C N S 2 2
10/4.4 16.5 1 (5 3 5) A 0.5 4.6 C N S 2 2
11/11.3 66.7 1 (4 3 3) E 0.5 10.6 C N S 2 2
12/15.3 45.4 1 (5 3 3) E 0.5 8.4 C N S 2 2
13/3.8 15.2 1 (5 3 5) A 1.4 4.8 C N N 2 2
14/5.3 19.8 1 (4 3 3) E 0.5 12.7 C N S 2 2
15/13.7 45.2 0* A 2.8 6.6 C C † † †
16/4.7 17.3 1 (5 3 5) A 1.9 7.7 C C C 1 1
17/2.6 13.8 1 (8 3 8) E 1.5 12.6 C N ‡ 1 ‡
Reopened PDA
18/4.7 18.1 1 (5 3 5) D 1.3 6.0 C N N 2 1
19/4.5 22.3 1 (5 3 5) B 1.0 1.0 C N N 2 1
20/8.6 28.8 1 (5 3 5) B 1.7 3.6 C N C 2 1
21/5.10 18.2 1 (5 3 5) A 1.0 1.8 C N C 2 1
22/13.9 60.6 1 (5 3 5) B 2.2 2.3 C N C 2 1
*Three coils attempted (8 cm 3 8 mm) and embolized to the pulmonary artery; a coil was not successfully deployed. †Patient underwent surgical ligation. ‡Patient
was lost to follow-up and did not complete the follow-up studies. C 5 continuous murmur; Diam 5 diameter; F/U 5 follow-up; N 5 no murmur; Post 5 after coil
occlusion; Pre 5 before coil occlusion; Pt 5 patient; S 5 systolic murmur; Wt 5 weight; 1 5 Doppler-echocardiographic (DE) evidence of patent ductus arteriosus
(PDA) shunt; 2 5 no evidence of PDA shunt by DE.
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PDA group when compared with all other PDA types (p ,
0.01).
Discussion
Our data demonstrate that despite successful coil occlusion
for PDA, many reopened. The early experience with PDA coil
occlusion found that large diameter PDAs were associated
with a higher incidence of coil embolization and a lower overall
success (7,8). More recently, large diameter PDAs have been
successfully coil occluded with a multiple-coil technique (9–
11). Our patient with the largest PDA diameter (2.8 mm) was
the only patient in which a coil could not be deployed. The
larger minimal diameter was the only factor identified as
contributing to procedural failure in this case. Despite this, in
comparing the patients with a reopened PDA with the rest of
the study group, the PDA minimal diameter was not a statis-
tically significant variable predictive for PDA reopening. In our
study, only short PDA length and angiographic type B PDA
were associated with reopening.
PDA reopening. In three of five patients whose PDA
reopened, a characteristic morphologic feature was found. The
aortic ampulla and the length of the PDA containing the
minimal diameter (the “occludable length”) was short (Fig.
1B). The type B PDA is described by many as a wide-diameter/
short-length PDA. Because the type B PDA is dependent on
short length, we expected and found that all those with type B
PDA were in the reopened PDA group. When analyzing our
data for large minimal diameter, no difference was found.
However, the PDA minimal diameter/PDA length ratio ap-
proached significance with the wide/short PDA (p 5 0.06).
Therefore, short length appears to be an independent factor
associated with reopening; however, if the PDA is wide and
short, this may add additional risk of reopening.
Others have also reported difficulty in coil occluding short,
type B PDA. Moore et al. (8) noted that residual PDA shunts
after coil occlusion were more common in type B PDA. Hijazi
and Geggel (9) were unable to coil occlude only 2 of 33 PDAs,
both of which were short.
We were able to successfully close short PDAs but only
temporarily. The minimal diameter of our patients with short-
length PDAs was considerably smaller than that reported by
either Hijazi and Geggel (9) or Moore et al. (8) and may have
been favorable for our initial success.
Shim et al. (13) reviewed 75 patients who underwent coil
occlusion and specifically evaluated the incidence of “recana-
lization” after coil occlusion. Because of the potential changes
in coil position, thrombus formation, clot retraction and
thrombolysis that may occur early after coil occlusion, they did
not consider DE performed immediately after the procedure
accurate for complete closure. Recanalization, in their study,
was considered to have occurred if PDA shunting was detected
in a patient with previous complete occlusion documented by
follow-up DE. Recanalization was not identified in the study by
Figure 2. Chest radiographs demonstrating late
PDA coil movement (Patient 22). A, Posteroante-
rior (top) and lateral (bottom) chest radiographs
from 2 months after PDA coil occlusion. B, Pos-
teroanterior (top) and left lateral (bottom) chest
radiographs 8 months after the procedure. The
chest radiographs demonstrate a change in the
position of the coil within the PDA.
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Shim et al. (13) nor in a study by Hijazi and Geggel (14) of 100
patients undergoing PDA coil occlusion.
We considered the PDA to be completely closed if DE was
negative for PDA shunting before hospital discharge. In most
patients, DE was performed the morning after the procedure.
Patient 22 was the only patient in whom follow-up DE was
negative 2 months after coil occlusion and positive for PDA
shunting at 8 months. In this particular patient, we docu-
mented a late change in coil position that accounted for the
reopening. This patient would have been identified as having
PDA recanalization by Shim et al. (13). Applying our defini-
tion of reopening, Shim et al. (13) would have identified two
patients with PDA reopening. By either definition, the finding
of a previously coil occluded PDA with subsequent reopening
may occur and appears by our data to be related to the PDA
length.
As Shim et al. (13) discussed, early dynamic changes in
thrombus formation may be involved in the process of early
successful closure but late PDA shunting. With a short PDA
and a short occludable length, there is a smaller and possibly
thinner thrombus formed within the PDA. Additionally, the
thrombus would have less surface area in contact with the
PDA, thereby creating an environment conducive for reopen-
ing. For Patient 22, the coil moved within the PDA sometime
between the 2- and 8-month follow-up evaluations and defines
the cause for reopening. For Patient 21, the coil moved toward
the pulmonary artery after deployment, and the final coil
position was not optimal. We suspect that reopening may have
occurred secondary to a lack of occludable PDA surface area
Figure 3. PDA reopening demonstrated angiographically when Pa-
tient 21 underwent a second coil occlusion procedure for PDA
reopening. Aorta cineangiograms in a straight lateral view. A, After the
initial coil procedure, coil position was not optimal, but no angio-
graphic shunt was detected. B, PDA reopening with contrast filling the
main and branch pulmonary arteries. Ao 5 aorta, PA 5 pulmonary
artery.
Figure 4. Scattergram comparing the PDA length with PDA minimal
diameter between the reopened group and all other patients. The
patients with reopened PDAs are represented by open circles (n 5 5),
and those with clinical reopening and a continuous murmur by solid
circles. All other patients are represented by squares (n 5 17). The
reopened group is segregated toward short PDA length but distributed
throughout the range of minimal diameter. Mean values for PDA
length and minimal diameter are shown for each group. Between the
two groups only the PDA length was statistically significant (p , 0.05).
Table 2. Comparison Between Reopened Patent Ductus Arteriosus
Group and All Other Patients
Variable
Reopened
PDA (n 5 5)
All Others
(n 5 17)
p
Value*
Age (yr) 7.4 6 4.0 6.7 6 4.4 NS
Weight (kg) 29.6 6 17.8 24.6 6 15.8 NS
Cath date (early)† 3 8 NS
Heparin use 4 12 NS
MAoP (mm Hg) 70.2 6 2.2 63.5 6 6.7 NS
MPAP (mm Hg) 13.0 6 1.0 16.6 6 4.9 NS
PDA type , 0.01‡
A 1 11
B 3 0
D 1 1
E 0 5
PDA min diam (mm) 1.4 6 0.5 1.2 6 0.7 NS
PDA length (mm) 2.9 6 1.9 7.1 6 3.2 , 0.05§
Coil diam/PDA min diam ratio 4.2 6 1.2 5.1 6 2.5 NS
PDA min diam/PDA length
ratio
0.64 6 0.35 0.21 6 0.14 NS\
*Logistic regression analysis was used to compare age, patient weight, mean
aortic pressure (MAoP), mean pulmonary artery pressure (MPAP), patent
ductus arteriosus (PDA) minimal diameter (min diam), PDA length, PDA coil
diameter/PDA minimal diameter ratio and PDA minimal diameter/PDA length
ratio; the Fisher exact test was used to compare catheterization (Cath) date,
heparin use and PDA type. †First 11 procedures for PDA coil occlusion. ‡PDA
type B was statistically significant between the two groups, with type B associated
with PDA reopening. §PDA length was statistically significant between the two
groups; short PDA length was associated with reopening. \PDA diameter/length
ratio approached significance (p 5 0.06); wide and short PDA was associated
with reopening. Data presented are mean value 6 SD or number of patients.
NS 5 p . 0.05.
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in contact with the coil, allowing for coil movement. In the
other three patients whose PDA reopened, coil movement was
not detected, final coil position was satisfactory with at least
two loops of coil at the aortic end of the ductus, and the
process for reopening was not clear.
Silent PDA reopening. Of the five patients with PDA
reopening, three (Patients 20, 21 and 22) had a continuous
murmur indicating clinical PDA reopening. The other two
patients had silent reopening. Based on the preference of the
parents and the primary cardiologist, Patient 21 underwent a
second coil occlusion procedure, and Patients 20 and 22 had
surgical ligation performed. The treatment for silent PDAs is
less well defined. Silent PDAs are reported to occur in 0.5% of
children with innocent murmurs (15). To date, there has been
only one case of endarteritis reported from a silent PDA (16).
Latson et al. (17) used an animal model with a PDA umbrella
device and found no additional risk of endocarditis after
occlusion when no shunt (n 5 8) or only a trivial shunt (n 5 2)
was present. They concluded that those patients with silent
PDAs after device closure require endocarditis prophylaxis,
but the risk does not warrant additional device closure or
surgical ligation. With PDA coil occlusion, animal models have
demonstrated ductal endothelialization around the coil, and
therefore, the risk for endarteritis is minimized (18).
We recommend endocarditis prophylaxis when there is a
silent PDA after coil occlusion. The current data on silent but
“coiled” PDAs are not sufficient to determine whether these
patients should undergo additional closure procedures or be
maintained on endocarditis prophylaxis indefinitely. Patient 19
refused a second coil procedure and underwent surgical liga-
tion, and Patient 18 is currently receiving endocarditis prophy-
laxis, with no plans for an additional procedure.
Short PDA length. In our study, PDAs reopened with a
length ,3.7 mm (n 5 4). The PDA length at which successful
coil occlusion becomes favorable is not known, but our data
would suggest that the shorter the PDA length, the less likely
the PDA will remained closed. Therefore, in patients with
short PDA length, alternative strategies to the current coil
occlusion technique should be considered.
The Gianturco coil and the Gianturco-Grifka vascular
occlusion device (GGVOD) (19) are the only transcatheter
PDA occlusion devices that are approved by the Food and
Drug Administration for widespread use. The Gianturco-
Grifka device has been successfully used with a wide range of
PDA diameters, but the device is not suitable for short-length
PDAs (19,20). The Rashkind PDA occluder has been used to
occlude short-length PDAs (21,22). However, their deploy-
ment requires a large delivery system (8F or 11F) unsuitable
for many patients, and there is a high incidence of residual
shunts. Using an adjustable buttoned device, Rao et al. (4)
have successfully closed short-length PDAs. The adjustable
buttoned device requires a 7F sheath and is not available for
general clinical use.
We are currently determining whether two-dimensional
echocardiography can accurately define the size and shape of
the PDA before closure. When a short-length or type B PDA
is encountered at catheterization, whether to proceed with coil
occlusion is not clearly known. If coil occlusion is attempted,
our study demonstrates that meticulous placement of the coil
within the ductus with at least two loops at the aortic end and
sizing the coil to be two times the minimal diameter of the
ductus is necessary but may not prevent reopening.
With short-length PDAs, adaptations to the current coil
technique should be considered. The preemptive placement of
more than one coil has not been studied for short PDAs but
has been successful for large-diameter PDAs (14). Lloyd et al.
(6) suggested that thrombin pretreatment of coils may reduce
residual shunting. The multiple-coil technique and thrombin
pretreatment of coils need further investigation with short
length PDAs.
Limitations of the study. The measurement of PDA length
requires that two separate lines are drawn and as such in-
creases the chance for variability in the final point–PDA length
(Fig. 1). Depending on where the long-axis line is started on
line A, the length may vary within 0.5 mm. This was most
apparent with a wide ampulla and an irregularly shaped
ductus. In every case, the line along the PDA long axis was
made in an attempt to maximize PDA length while staying
within the PDA long axis.
Conclusions. Transcatheter coil occlusion is an effective
method for closing a PDA. Previous reports have demon-
strated that success is associated with the minimal diameter of
the PDA. Despite all our patients having small minimal
diameter PDAs, we found PDA reopening in five patients.
Short PDA length was the only independent variable that
significantly predicted PDA reopening. Type B PDA, which is
dependent on short length, was associated with PDA reopen-
ing. Our data would suggest that in the presence of a short
PDA length and type B PDA, alternative strategies to the
current coil occlusion technique should be considered.
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